✦ LIBER ✦

Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling

✍ Scribed by Sue Goo Rhee; Ho Zoon Chae; Kanghwa Kim

Book ID: 113629550
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 203 KB
Volume: 38
Category: Article
ISSN: 0891-5849
DOI: 10.1016/j.freeradbiomed.2005.02.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peroxiredoxins: A historical overview an

Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling

✍ Sue Goo Rhee; Ho Zoon Chae; Kanghwa Kim 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 203 KB

The observation that purified yeast glutamine synthetase is rapidly inactivated in a thiol-containing buffer yet retains activity in crude extracts containing the same thiol led to our discovery of an enzyme that protects against oxidation in a thiol-containing system. This novel antioxidant enzyme

PP28 Stromal cell-derived factor-1 signa

PP28 Stromal cell-derived factor-1 signaling: A novel mechanism of synovial induction of cartilage in rheumatoid arthritis and osteoarthritis

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 283 KB

[Cancer Metastasis - Biology and Treatme

[Cancer Metastasis - Biology and Treatment] Signal Transduction in Cancer Metastasis Volume 15 || New Concepts on the Critical Functions of Cancer- and Metastasis-Initiating Cells in Treatment Resistance and Disease Relapse: Molecular Mechanisms, Signaling Transduction Elements and Novel Targeting Therapies

✍ Wu, Wen-Sheng; Hu, Chi-Tan 📂 Article 📅 2010 🏛 Springer Netherlands ⚖ 761 KB

Multiple mechanisms of action of ZR2002

Multiple mechanisms of action of ZR2002 in human breast cancer cells: A novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA

✍ Fouad Brahimi; Zakaria Rachid; Qiyu Qiu; James P. McNamee; Yu-Jiang Li; Ana M. T 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 276 KB 👁 2 views

## Abstract The mechanism of action of ZR2002, a chimeric amino quinazoline designed to possess mixed EGFR tyrosine kinase (TK) inhibitory and DNA targeting properties, was compared to those of ZR01, a reversible inhibitor of the same class and PD168393, a known irreversible inhibitor of EGFR. ZR20